Page last updated: 2024-08-24

capecitabine and Cirrhosis, Liver

capecitabine has been researched along with Cirrhosis, Liver in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Gao, YY; Qian, BX; Song, DZ; Zhang, X1
Barbera, MA; Brandi, G; De Lorenzo, S; Frega, G; Garajovà, I; Garuti, F; Palloni, A; Rizzo, A; Tovoli, F; Trevisani, F1
Battisti, S; Guida, FM; Pagliara, E; Santini, D; Tonini, G; Zobel, BB1
Eckel, F; Lersch, C; Mayr, M; Schmid, RM; Schulte-Frohlinde, E; Stock, K; von Delius, S1
Aguayo, A; Patt, YZ1

Reviews

1 review(s) available for capecitabine and Cirrhosis, Liver

ArticleYear
Nonsurgical treatment of hepatocellular carcinoma.
    Seminars in oncology, 2001, Volume: 28, Issue:5

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Capecitabine; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cryosurgery; Deoxycytidine; Drug Combinations; Ethanol; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Injections, Intralesional; Interferons; Liver Cirrhosis; Liver Neoplasms; Octreotide; Radiopharmaceuticals; Radiotherapy Dosage; Tamoxifen; Tegafur; Uracil

2001

Other Studies

4 other study(ies) available for capecitabine and Cirrhosis, Liver

ArticleYear
Isolated gastric variceal bleeding related to non-cirrhotic portal hypertension following oxaliplatin-based chemotherapy: A case report.
    World journal of gastroenterology, 2022, Jul-21, Volume: 28, Issue:27

    Topics: Capecitabine; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Oxaliplatin

2022
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept.
    Scientific reports, 2018, 07-03, Volume: 8, Issue:1

    Topics: Administration, Metronomic; Adult; Aged; Aged, 80 and over; Capecitabine; Carcinoma, Hepatocellular; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Proof of Concept Study; Propensity Score; Prospective Studies; Retrospective Studies; Survival Rate; Treatment Outcome

2018
Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
    Clinical colorectal cancer, 2014, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; ErbB Receptors; Fluorouracil; Humans; Leucovorin; Liver Cirrhosis; Liver Neoplasms; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin

2014
Capecitabine for treatment of advanced hepatocellular carcinoma.
    Hepato-gastroenterology, 2007, Volume: 54, Issue:80

    Topics: Aged; Antimetabolites, Antineoplastic; Bilirubin; Capecitabine; Carcinoma, Hepatocellular; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Treatment Outcome

2007